SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 72 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $123,000 | -20.6% | 226,190 | -21.4% | 0.00% | – |
| Q1 2016 | $155,000 | -50.0% | 287,607 | -17.0% | 0.00% | – |
| Q4 2015 | $310,000 | -49.8% | 346,601 | -54.6% | 0.00% | – |
| Q3 2015 | $618,000 | -83.1% | 762,608 | -37.4% | 0.00% | -100.0% |
| Q2 2015 | $3,664,000 | -15.9% | 1,217,380 | -31.5% | 0.00% | -50.0% |
| Q1 2015 | $4,356,000 | +298.9% | 1,777,488 | +315.1% | 0.00% | – |
| Q4 2014 | $1,092,000 | -90.6% | 428,201 | -73.7% | 0.00% | -100.0% |
| Q3 2014 | $11,606,000 | +71.5% | 1,625,500 | +56.6% | 0.00% | +33.3% |
| Q2 2014 | $6,766,000 | +22.1% | 1,037,734 | +23.8% | 0.00% | 0.0% |
| Q1 2014 | $5,542,000 | +804.1% | 838,400 | +548.1% | 0.00% | – |
| Q4 2013 | $613,000 | -23.1% | 129,358 | -15.5% | 0.00% | – |
| Q2 2013 | $797,000 | – | 153,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
| RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
| GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
| Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
| DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
| Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
| Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
| EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |